BVF INC/IL Diversified Active

Location: San Francisco, CA

CIK: 0001056807 · Show all filings

Period: Q2 2015 (← Previous) (Next →)

Filing Date: Aug 14, 2015

Total Value: $567M (93.4% shares, 6.6% debt)

Holdings (30)

— ARRAY BIOPHARMA INC 11.7%

Value $66.11M Shares 9,169,276 Est. Cost — Unrealized —

— CHEMOCENTRYX INC 10.6%

Value $59.83M Shares 7,270,013 Est. Cost — Unrealized —

— BLUEPRINT MEDICINES CORP 7.4%

Value $41.92M Shares 1,582,408 Est. Cost — Unrealized —

— FORWARD PHARMA A/S 6.8%

Value $38.39M Shares 1,008,981 Est. Cost — Unrealized —

— CONCERT PHARMACEUTICALS INC 6.6%

Value $37.54M Shares 2,521,452 Est. Cost — Unrealized —

— ONCOTHYREON INC 6.4%

Value $36.48M Shares 9,754,178 Est. Cost — Unrealized —

— EXELIXIS INC 6.0%

Value $34.01M Shares 38,239,000 Est. Cost — Unrealized —

— LOXO ONCOLOGY INC 5.1%

Value $29.12M Shares 1,615,081 Est. Cost — Unrealized —

— ONCOMED PHARMACEUTICALS INC 5.0%

Value $28.46M Shares 1,264,715 Est. Cost — Unrealized —

IRWD IRONWOOD PHARMACEUTICALS INC 4.6%

Value $26.18M Shares 2,171,108 Est. Cost — Unrealized —

— VITAE PHARMACEUTICALS INC 4.1%

Value $23.11M Shares 1,604,615 Est. Cost — Unrealized —

— TOBIRA THERAPEUTICS INC 3.6%

Value $20.27M Shares 1,175,233 Est. Cost — Unrealized —

— TARGACEPT INC 3.3%

Value $18.57M Shares 6,655,128 Est. Cost — Unrealized —

— GTX INC DEL 2.8%

Value $15.84M Shares 10,772,306 Est. Cost — Unrealized —

— QLT INC 2.7%

Value $15.44M Shares 3,737,446 Est. Cost — Unrealized —

CYTK CYTOKINETICS INC 2.5%

Value $14.16M Shares 2,106,989 Est. Cost — Unrealized —

EXEL EXELIXIS INC 1.8%

Value $10.4M Shares 2,766,152 Est. Cost — Unrealized —

— ARQULE INC 1.8%

Value $10.29M Shares 6,430,708 Est. Cost — Unrealized —

— SEATTLE GENETICS INC 1.7%

Value $9.68M Shares 200,000 Est. Cost — Unrealized —

XENE XENON PHARMACEUTICALS INC 1.4%

Value $7.826M Shares 678,764 Est. Cost — Unrealized —

— FIVE PRIME THERAPEUTICS INC 1.1%

Value $5.976M Shares 240,597 Est. Cost — Unrealized —

— ARRAY BIOPHARMA INC 0.6%

Value $3.169M Shares 2,500,000 Est. Cost — Unrealized —

— CATABASIS PHARMACEUTICALS IN 0.5%

Value $2.747M Shares 225,000 Est. Cost — Unrealized —

— MAST THERAPEUTICS INC 0.4%

Value $2.505M Shares 5,111,293 Est. Cost — Unrealized —

— ATYR PHARMA INC 0.4%

Value $2.495M Shares 134,725 Est. Cost — Unrealized —

— ONCOGENEX PHARMACEUTICALS IN 0.4%

Value $2.377M Shares 1,020,108 Est. Cost — Unrealized —

GBIM GLOBEIMMUNE INC 0.3%

Value $1.771M Shares 678,400 Est. Cost — Unrealized —

— BIOTA PHARMACEUTIALS INC 0.1%

Value $726K Shares 350,776 Est. Cost — Unrealized —

— ACHAOGEN INC 0.1%

Value $643K Shares 106,700 Est. Cost — Unrealized —

— APTOSE BIOSCIENCES INC 0.1%

Value $538K Shares 105,429 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	ARRAY BIOPHARMA INC	9,169,276	$66.11M	11.7%	—	—	COM	04269X105
—	CHEMOCENTRYX INC	7,270,013	$59.83M	10.6%	—	—	COM	16383L106
—	BLUEPRINT MEDICINES CORP	1,582,408	$41.92M	7.4%	—	—	COM	09627Y109
—	FORWARD PHARMA A/S	1,008,981	$38.39M	6.8%	—	—	SPONSORED ADR	34986J105
—	CONCERT PHARMACEUTICALS INC	2,521,452	$37.54M	6.6%	—	—	COM	206022105
—	ONCOTHYREON INC	9,754,178	$36.48M	6.4%	—	—	COM	682324108
—	EXELIXIS INC	38,239,000	$34.01M	6.0%	—	—	NOTE 4.250% 8/1	30161QAC8
—	LOXO ONCOLOGY INC	1,615,081	$29.12M	5.1%	—	—	COM	548862101
—	ONCOMED PHARMACEUTICALS INC	1,264,715	$28.46M	5.0%	—	—	COM	68234X102
IRWD	IRONWOOD PHARMACEUTICALS INC	2,171,108	$26.18M	4.6%	—	—	COM CL A	46333X108
—	VITAE PHARMACEUTICALS INC	1,604,615	$23.11M	4.1%	—	—	COM	92847N103
—	TOBIRA THERAPEUTICS INC	1,175,233	$20.27M	3.6%	—	—	COM	88883P101
—	TARGACEPT INC	6,655,128	$18.57M	3.3%	—	—	COM	87611R306
—	GTX INC DEL	10,772,306	$15.84M	2.8%	—	—	COM	40052B108
—	QLT INC	3,737,446	$15.44M	2.7%	—	—	COM	746927102
CYTK	CYTOKINETICS INC	2,106,989	$14.16M	2.5%	—	—	COM NEW	23282W605
EXEL	EXELIXIS INC	2,766,152	$10.4M	1.8%	—	—	COM	30161Q104
—	ARQULE INC	6,430,708	$10.29M	1.8%	—	—	COM	04269E107
—	SEATTLE GENETICS INC	200,000	$9.68M	1.7%	—	—	COM	812578102
XENE	XENON PHARMACEUTICALS INC	678,764	$7.826M	1.4%	—	—	COM	98420N105
—	FIVE PRIME THERAPEUTICS INC	240,597	$5.976M	1.1%	—	—	COM	33830X104
—	ARRAY BIOPHARMA INC	2,500,000	$3.169M	0.6%	—	—	NOTE 3.000% 6/0	04269XAA3
—	CATABASIS PHARMACEUTICALS IN	225,000	$2.747M	0.5%	—	—	COM	14875P107
—	MAST THERAPEUTICS INC	5,111,293	$2.505M	0.4%	—	—	COM	576314108
—	ATYR PHARMA INC	134,725	$2.495M	0.4%	—	—	COM	002120103
—	ONCOGENEX PHARMACEUTICALS IN	1,020,108	$2.377M	0.4%	—	—	COM	68230A106
GBIM	GLOBEIMMUNE INC	678,400	$1.771M	0.3%	—	—	COM	37957B100
—	BIOTA PHARMACEUTIALS INC	350,776	$726K	0.1%	—	—	COM	090694100
—	ACHAOGEN INC	106,700	$643K	0.1%	—	—	COM	004449104
—	APTOSE BIOSCIENCES INC	105,429	$538K	0.1%	—	—	COM NEW	03835T200